Suspensions for Anti-Doping Rule Violations
| Athlete | Violation Date | ADRV | Substance | Term | Start | End | Info |
|---|---|---|---|---|---|---|---|
| Chleo Van Wyk | 2014-10-18 | Presence, Use | Ostarine glucuronide | Indefinite | 2014-10-18 | Indefinite | Athlete retired |
| Ash Goulevitch | 2016-06-26 2018-02-24 | Refusal/failure to comply Breach of period of ineligibility | 8 years | 2016-11-03 | 2024-11-02 | link | |
| Christine Ashcroft | 2016-09-23 to 2018-02-21 | Presence, Use, Posession | Testosterone Androsterone Etiocholanolone 5β-androstane-3α,17β-diol Growth Hormone | 4 years | 2018-03-21 | 2022-03-21 | link |
| Jessica Gray | 2017-10-21 2018-01-16 2019-09-21 | Presence, Use Possession Breach of period of ineligibility | Nandrolone; Norandrostenedione or Norandrostenediol, Dehydroeplandrosterone Dehydroeplandrosterone | 8 years | 2018-01-16 | 2026-01-16 | link link |
| David Johnston | 2018-02-03 | Presence, Use | Ostarine O-Dephenyl Ostarine | 4 years | 2018-05-02 | 2022-05-02 | link |
| Patrick Packer | 2018-07-01 2018-07-01 2019-01-20 | Posession, Use Posession, Use Presence | Metandienone Testosterone Propionate; and/or Testosterone; and/or Testosterone Decanoate; and/or Dromostanolone Enanthate; and/or Testosterone Isocaproate; and/or Testosterone Enanthate 2a-methyl-3a-hydroxy-5a-androstan-17-one (metabolite of Drostanolone) | 4 years | 2019-01-20 | 2023-01-20 | link |
